Provexis plc (PXS.L)
PXS.L Stock Price Chart
Explore Provexis plc interactive price chart. Choose custom timeframes to analyze PXS.L price movements and trends.
PXS.L Company Profile
Discover essential business fundamentals and corporate details for Provexis plc (PXS.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
28 Jun 2004
Employees
2.00
Website
https://www.provexis.comCEO
Ian Ford BA ACA,
Description
Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. Provexis plc has a collaboration agreement with By-Health Co., Ltd. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.
PXS.L Financial Timeline
Browse a chronological timeline of Provexis plc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Dec 2025
Earnings released on 27 Dec 2024
EPS came in at -£0.00 , while revenue for the quarter reached £785.35K .
Earnings released on 27 Sept 2024
EPS came in at -£0.00 , while revenue for the quarter reached £414.43K .
Earnings released on 29 Dec 2023
EPS came in at -£0.00 , while revenue for the quarter reached £387.53K .
Earnings released on 28 Sept 2023
EPS came in at -£0.00 , while revenue for the quarter reached £210.55K .
Earnings released on 30 Dec 2022
EPS came in at -£0.00 , while revenue for the quarter reached £179.37K .
Earnings released on 31 Mar 2022
EPS came in at -£0.00 , while revenue for the quarter reached £426.17K .
Earnings released on 30 Sept 2021
EPS came in at -£0.00 , while revenue for the quarter reached £211.20K .
Earnings released on 31 Mar 2021
EPS came in at -£0.00 , while revenue for the quarter reached £268.26K .
Earnings released on 30 Sept 2020
EPS came in at -£0.00 , while revenue for the quarter reached £237.08K .
PXS.L Stock Performance
Access detailed PXS.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.